Canadian Treat-And-Extend Trial With Ranibizumab In Namd Patients: Cantreat 36 Month Anatomic Outcomes

INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE(2020)

引用 0|浏览4
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要